NYSE:ANVS
Annovis Bio, Inc. Stock News
$8.31
+0.280 (+3.49%)
At Close: May 17, 2024
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Annovis Bio, Inc. (“Annovis” or the “Com
DEADLINE NEXT WEEK: Annovis Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ANVS
09:34am, Monday, 11'th Oct 2021
San Diego, California--(Newsfile Corp. - October 11, 2021) - Robbins Geller Rudman & Dowd LLP announces that purchasers of Annovis Bio, Inc. (NYSE American: ANVS) securities between May 21, 2021 and
New York, New York--(Newsfile Corp. - October 11, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANVS, VIEW and HYZN
10:35am, Sunday, 10'th Oct 2021
NEW YORK, NY / ACCESSWIRE / October 10, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies
New York, New York--(Newsfile Corp. - October 9, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS) and cert
NEW YORK, Oct. 9, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Annovis Bio, Inc. (NYSE: ANVS) between May 21, 2021 and July 28,
New York, New York--(Newsfile Corp. - October 8, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a sec
Los Angeles, California--(Newsfile Corp. - October 8, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Annovis Bio, Inc
NEW YORK, Oct. 7, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS) and certain of its office
Los Angeles, California--(Newsfile Corp. - October 7, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Annovis Bio, Inc
New York, New York--(Newsfile Corp. - October 7, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
New York, New York--(Newsfile Corp. - October 6, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Annovis Bio, Inc. (NYSE Ameri
New York, New York--(Newsfile Corp. - October 5, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
NEW YORK, Oct. 4, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class act
RADNOR, Pa., Oct. 4, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against Annovis Bio, Inc. (NY
